Found: 35
Select item for more details and to access through your institution.
Regarding the Article by Rugo et al.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1285, doi. 10.1002/onco.13781
- By:
- Publication type:
- Article
Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 533, doi. 10.1002/onco.13850
- By:
- Publication type:
- Article
COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1156, doi. 10.1002/onco.13791
- By:
- Publication type:
- Article
Good Quality Care for Cancer Patients Dying in Hospitals, but Information Needs Unmet: Bereaved Relatives' Survey within Seven Countries.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1273, doi. 10.1002/onco.13837
- By:
- Publication type:
- Article
Patient‐Reported Outcomes Predict Progression‐Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 562, doi. 10.1002/onco.13806
- By:
- Publication type:
- Article
Trend in Stereotactic Radiation Therapy Use for Management of Bone and Brain Metastases in Patients with Renal Cell Carcinoma in Australia.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1288, doi. 10.1002/onco.13792
- By:
- Publication type:
- Article
Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP‐NETs: A Review of Key Issues.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1171, doi. 10.1002/onco.13847
- By:
- Publication type:
- Article
Views from Multidisciplinary Oncology Clinicians on Strengthening Cancer Care Delivery Systems in Tanzania.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1197, doi. 10.1002/onco.13834
- By:
- Publication type:
- Article
Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1240, doi. 10.1002/onco.13820
- By:
- Publication type:
- Article
Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource‐Limited Context.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1189, doi. 10.1002/onco.13818
- By:
- Publication type:
- Article
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1125, doi. 10.1002/onco.13816
- By:
- Publication type:
- Article
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1205, doi. 10.1002/onco.13812
- By:
- Publication type:
- Article
Evaluation of the Association of Polymorphisms With Palbociclib‐Induced Neutropenia: Pharmacogenetic Analysis of PALOMA‐2/‐3.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1143, doi. 10.1002/onco.13811
- By:
- Publication type:
- Article
Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1250, doi. 10.1002/onco.13805
- By:
- Publication type:
- Article
Effectiveness of Alpelisib + Fulvestrant Compared with Real‐World Standard Treatment Among Patients with HR+, HER2–, PIK3CA‐Mutated Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1133, doi. 10.1002/onco.13804
- By:
- Publication type:
- Article
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1263, doi. 10.1002/onco.13801
- By:
- Publication type:
- Article
Post Hoc Health‐Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1179, doi. 10.1002/onco.13803
- By:
- Publication type:
- Article
Neoadjuvant Everolimus for Adult Giant Mesenteric Cystic Lymphangioma with mTOR Pathway Activation.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 554, doi. 10.1002/onco.13775
- By:
- Publication type:
- Article
Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1110, doi. 10.1002/onco.13797
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1286, doi. 10.1002/onco.13782
- By:
- Publication type:
- Article
Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 597, doi. 10.1002/onco.13789
- By:
- Publication type:
- Article
Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1161, doi. 10.1002/onco.13786
- By:
- Publication type:
- Article
Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 588, doi. 10.1002/onco.13767
- By:
- Publication type:
- Article
Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 537, doi. 10.1002/onco.13749
- By:
- Publication type:
- Article
Analysis of Real‐World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death‐1 and Programmed Cell Death‐Ligand 1 Inhibitors in Advanced Non‐Small Cell Lung Cancers.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1226, doi. 10.1002/onco.13780
- By:
- Publication type:
- Article
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 560, doi. 10.1002/onco.13777
- By:
- Publication type:
- Article
Immune‐Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1216, doi. 10.1002/onco.13776
- By:
- Publication type:
- Article
Adherence to Guideline‐Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER‐Medicare Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 579, doi. 10.1002/onco.13763
- By:
- Publication type:
- Article
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1104, doi. 10.1002/onco.13758
- By:
- Publication type:
- Article
Overview of Ocular Side Effects of Selinexor.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 619, doi. 10.1002/onco.13756
- By:
- Publication type:
- Article
Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 610, doi. 10.1002/onco.13730
- By:
- Publication type:
- Article
Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case Report.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 549, doi. 10.1002/onco.13728
- By:
- Publication type:
- Article
Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two‐Cohort, Phase Ib/II Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1256, doi. 10.1002/onco.13726
- By:
- Publication type:
- Article
Circulating Tumor DNA‐Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 569, doi. 10.1002/onco.13717
- By:
- Publication type:
- Article
Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 558, doi. 10.1002/onco.13682
- By:
- Publication type:
- Article